Latest ITCI reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Intra-Cellular Therapies
  4. Financial Ratios
Intra-Cellular Therapies logo
Intra-Cellular Therapies ITCI
$ 65.56 -2.15%
mail-toReport an Error

Intra-Cellular Therapies Financial Ratios 2011-2024 | ITCI

Annual Financial Ratios Intra-Cellular Therapies

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -236.9 -105.4 -15.0 -9.9 -8.6 -4.1 -8.0 -5.0 -12.8 -18.1 -12.2 - -

P/S

 51.3 52.8 50.7 98.1 20913.5 - 3201.1 1742.9 14638.7 963.8 119.8 - -

EPS

 -0.3 -0.5 -3.5 -3.2 -2.7 -2.8 -2.1 -2.7 -2.9 -1.1 -1.6 -3.0 -

EV (Enterprise Value)

 6.76 B 4.59 B 4.23 B 2.24 B 1.22 B 624 M 766 M 541 M 1.3 B 506 M 293 M -12.8 M -13.7 M

EBITDA per Share

 -1.66 -2.8 -3.51 -3.28 -2.78 -2.96 -2.22 -2.73 -2.93 -1.08 - - -

EV/EBITDA

 -14.7 -9.5 -7.6 -3.6 -7.3 -4.5 -12.2 -16.0 -11.2 - -

PEG

 28.19 -16.54 -2.24 -2.51 1.52 -0.12 0.38 0.65 -0.07 0.58 -0.0 - -

P/B

 11.4 7.1 10.2 3.4 6.5 2.0 1.7 1.5 2.8 4.6 10.4 - -

P/CF

 -54.5 -17.2 -16.4 -9.7 -9.9 -5.4 -9.7 -6.3 -13.0 -24.4 -14.5 - -

ROE %

 -4.83 -6.71 -67.99 -34.56 -75.75 -48.83 -21.52 -31.01 -22.00 -25.46 -84.98 - -

ROA %

 -3.92 -5.83 -57.99 -31.65 -58.81 -43.43 -20.74 -29.94 -21.65 -23.41 -69.88 - -

ROCE %

 -26.95 -40.18 -68.36 -35.20 -71.65 -50.56 -22.49 -31.25 -22.14 -25.70 -83.08 - -

Current Ratio

 5.3 7.6 6.8 11.9 6.4 9.8 33.0 36.9 77.2 12.4 5.6 - -

DSO

 261.4 198.0 67.3 86.1 - - - 104.1 122.5 32.6 44.9 - -

DIO

 - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - -

Operating Cycle

 261.4 198.0 67.3 86.1 - - - - - - - - -

Cash Conversion Cycle

 261.4 198.0 67.3 86.1 - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Intra-Cellular Therapies

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.16 - -0.25 -0.45 -0.46 - -0.57 -0.92 -0.78 -1.05 -0.95 -0.85 -0.65 -0.76 -0.79 -0.96 -0.73 -0.73 -0.63 -0.68 -0.63 -0.75 -0.76 -0.68 -0.65 -0.56 -0.53 -0.41 -0.62 -0.64 -0.7 -0.71 -0.64 -0.67 -0.91 -0.61 -0.72 -0.52 -0.22 -0.15 -0.17 -0.36 -0.42 -0.56 -0.39 - -0.4 - - - - - -

EBITDA per Share

 -0.21 - - - -0.51 - -0.58 -0.93 -0.78 - -0.95 -0.85 -0.66 - -0.8 -0.97 -0.75 - -0.66 -0.71 -0.66 - -0.79 -0.71 -0.68 - -0.54 -0.43 -0.64 - -0.69 -0.73 -0.66 - -0.91 -0.62 -0.73 - -0.22 -0.16 -0.17 - -0.27 -0.55 -0.37 - -0.39 - - - - - -

ROE %

 -17.67 -18.10 -25.91 -29.68 -34.62 -28.90 -49.41 -57.40 -57.83 -57.35 -46.07 -38.68 -35.96 -34.56 -46.13 -55.61 -65.11 -75.75 -67.77 -62.96 -55.52 -48.83 -42.65 -34.61 -26.76 -21.52 -22.19 -25.21 -29.52 -31.01 -29.74 -28.43 -24.74 -22.00 -28.56 -27.13 -26.37 -25.46 -38.28 -48.50 -70.92 -84.98 -150.41 -225.74 -199.55 -90.86 -90.86 - - - - - -

ROA %

 -14.80 -15.48 -22.32 -25.78 -30.45 -25.81 -43.31 -50.28 -50.60 -50.11 -41.08 -34.96 -32.86 -31.65 -39.34 -45.53 -51.55 -58.81 -54.06 -51.81 -47.36 -43.43 -38.43 -31.65 -24.96 -20.74 -21.40 -24.33 -28.49 -29.94 -28.83 -27.69 -24.20 -21.65 -27.28 -25.53 -24.55 -23.41 -32.73 -40.61 -58.68 -69.88 -126.81 -191.88 -170.35 -77.85 -77.85 - - - - - -

ROCE %

 - - -8.12 -16.23 -28.41 -29.46 -45.34 -53.11 -53.43 -37.07 -45.58 -38.21 -35.60 -25.86 -44.52 -54.66 -64.87 -57.56 -71.22 -66.22 -58.46 -37.66 -42.85 -34.39 -26.13 -15.33 -23.32 -26.11 -30.37 -23.85 -30.65 -29.45 -25.66 -16.02 -21.41 -20.02 -19.30 -13.01 -28.15 -37.89 -59.52 -57.67 -70.76 -68.70 -43.24 -13.08 -13.08 - - - - - -

Current Ratio

 5.1 5.3 6.1 6.7 7.6 7.7 8.1 9.1 11.4 6.8 7.9 8.7 10.8 11.9 11.9 11.9 11.9 4.5 4.5 4.5 4.5 9.1 9.1 9.1 9.1 27.6 27.6 27.6 27.6 29.0 29.0 29.0 29.0 61.6 61.6 61.6 61.6 12.4 12.4 12.4 12.4 - - - - - - - - - - - -

DSO

 77.2 - 71.8 73.1 75.0 - 68.9 65.5 69.1 65.9 66.0 65.7 70.3 79.0 133.3 515.2 453.3 - - - - - - - - 56.9 101.2 51.8 77.8 87.9 1973.5 37.7 - 91.2 46.1 48.8 1132.2 71.5 37.9 21.5 105.5 37.1 45.9 47.7 48.6 - 36.3 - - - - - -

DIO

 - - - - - - - - - - - - - - - - 4665.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - 8547.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 77.2 - 71.8 73.1 75.0 - 68.9 65.5 69.1 65.9 66.0 65.7 70.3 79.0 133.3 515.2 5119.2 - - - - - - - - 56.9 101.2 51.8 77.8 87.9 1973.5 37.7 - 91.2 46.1 48.8 1132.2 71.5 37.9 21.5 105.5 37.1 45.9 47.7 48.6 - 36.3 - - - - - -

Cash Conversion Cycle

 77.2 - 71.8 73.1 75.0 - 68.9 65.5 69.1 65.9 66.0 65.7 70.3 79.0 133.3 515.2 -3428.4 - - - - - - - - 56.9 101.2 51.8 77.8 87.9 1973.5 37.7 - 91.2 46.1 48.8 1132.2 71.5 37.9 21.5 105.5 37.1 45.9 47.7 48.6 - 36.3 - - - - - -

All numbers in USD currency